hCCR8(2)/hCTLA-4

Nomenclature

C57BL/6Smoc-Ccr8tm3(hCCR8)Ctla4tm1(hCTLA4)Smoc

Cat. NO.

NM-HU-220074

Strain State

Embryo cryopreservation

Export PDF

Model Description

hCTLA4 (NM-HU-00014) mice were crossed with hCCR8(2) (NM-HU-2000054) mice to generate hCCR8(2)/hCTLA4 mice．

Validation Data

image.png

Fig1. Statistics of hCCR8 and hCTLA-4 expression in hCCR8(2)/hCTLA-4 dKI mice.

image.png

Fig2. Detection of hCCR8 and CTLA-4 expression on T cells in Tumor in hCCR8(2)/hCTLA-4 dKI mice.

image.png

Fig3. Detection of hCCR8 and hCTLA-4 expression on T cells in Spleen in hCCR8(2)/hCTLA-4 dKI mice.

You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Workshop：Progress and Advances in Preclinical immuno-Oncology Research

SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.

Learn more